OncoMed Pharmaceuticals Inc Cash, Period Increase (Decrease)
OncoMed Pharmaceuticals Inc reported Cash, Period Increase (Decrease) of $2.24 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-08.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2017-05-08
- OncoMed Pharmaceuticals Inc cash, period increase (decrease) for the quarter ending 2017-03-31 was $2.24M, a 95.14% decline year-over-year.
- OncoMed Pharmaceuticals Inc cash, period increase (decrease) for the quarter ending 2016-03-31 was $46.12M.
- OncoMed Pharmaceuticals Inc cash, period increase (decrease) for fiscal 2016 was -$1.49M, a 114.47% decline from fiscal 2015.
- OncoMed Pharmaceuticals Inc cash, period increase (decrease) for fiscal 2015 was $10.31M.
- OncoMed Pharmaceuticals Inc cash, period increase (decrease) for fiscal 2014 was -$180.79M.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|
| 2017-03-31 | $2.24M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | -$1.49M 10-K · filed 2017-03-09 | |
| 2016-03-31 | $46.12M 10-Q · filed 2017-05-08 | |
| 2015-12-31 | $10.31M 10-K · filed 2017-03-09 | |
| 2014-12-31 | -$180.79M 10-K · filed 2017-03-09 |